Provided by Tiger Trade Technology Pte. Ltd.

CHINARES PHARMA

4.300
-0.064-1.47%
Volume:16.35M
Turnover:70.38M
Market Cap:27.02B
PE:5.72
High:4.380
Open:4.365
Low:4.275
Close:4.364
52wk High:6.336
52wk Low:4.211
Shares:6.28B
HK Float Shares:6.28B
Volume Ratio:1.42
T/O Rate:0.26%
Dividend:0.22
Dividend Rate:5.07%
EPS(LYR):0.752
ROE:8.32%
ROA:2.64%
PB:0.44
PE(LYR):5.72
PS:0.08

Loading ...

CHINARES PHARMA's Unit Kpc Pharmaceuticals Swings to Q1 Loss

Stock News
·
Apr 24

China Resources Pharmaceutical Group Ltd - Kpc Q1 Net Loss at RMB 144.8 Mln

THOMSON REUTERS
·
Apr 24

China Resources Pharmaceutical Group Ltd - Kpc Q1 Revenue at RMB 836.2 Mln

THOMSON REUTERS
·
Apr 24

CR Sanjiu Q1 2026: Revenue Jumps 18.6% but Net Profit Slips 9.1%; Cash Outflow Weighs on China Resources Pharmaceutical Subsidiary

Bulletin Express
·
Apr 24

BRIEF-China Resources Pharmaceutical Says QTRLY Net Profit For CR Jiangzhong RMB312.0 MLN

Reuters
·
Apr 24

CHINARES PHARMA Subsidiary Tasly Pharmaceutical Delivers 5.35% Revenue and 9.78% Profit Growth in Q1 2026

Bulletin Express
·
Apr 24

CR Pharma’s Dong-E-E-Jiao Posts 7.1% Profit Growth in Q1 2026, Cash Reserves Surge

Bulletin Express
·
Apr 24

CR Double-Crane Q1 2026 Revenue Down 8.84%, Net Profit Declines 4.08%; Majority-Owned by CR Pharma

Bulletin Express
·
Apr 24

CR Double-Crane Q1 net profit falls to RMB 501.38 million

Reuters
·
Apr 24

Dong-E-E-Jiao Q1 net profit rises to RMB 454.77 million

Reuters
·
Apr 24

China Resources Pharma's Dong-E-E-Jiao Reports Q1 Net Profit of 455 Million Yuan, Up 7.12%

Stock News
·
Apr 24

China Resources Pharmaceutical - China Resources Double-Crane Pharmaceutical Q1 Revenue RMB2.81 Bln

THOMSON REUTERS
·
Apr 24

CR Pharma Completes RMB1.50 Billion First-Tranche Issuance of 2026 Corporate Bonds at 1.65% Coupon

Bulletin Express
·
Apr 16

China Resources Pharma Subsidiary Concludes RMB 1.5 Billion Corporate Bond Issuance

Stock News
·
Apr 16

China Resources Pharma unit issues RMB 1.5 billion three-year bonds at 1.65%

Reuters
·
Apr 16

BrainAurora appoints Yang Fan, Wang Jingbo as non-executive directors

Reuters
·
Apr 15

DIARY-China corporate earnings week ahead

Reuters
·
Apr 03

CHINARES PHARMA Keeps Share Base Unchanged at 6.28 Billion in March 2026, Confirms Public Float Compliance

Bulletin Express
·
Apr 01

A Look At China Resources Pharmaceutical Group (SEHK:3320) Valuation After 2025 Results And Higher Dividend Proposal

Simply Wall St.
·
Mar 30

CHINARES PHARMA Subsidiary CR Pharmaceutical Commercial Completes RMB1.80 Billion First-Tranche 2026 Bond Issue at 1.70% Coupon

Bulletin Express
·
Mar 27